5 alpha-reductase inhibitors inhibit the conversion of testosterone to dihydrotestosterone. Dihydrotestosterone is more potent than testosterone in supporting prostatic hypertrophy.
Inhibition of 5-alpha reductase marginally improves flow rates and symptoms in men with bladder outflow obstruction due to benign prostatic hypertrophy.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.